Evidence map›Paper›PMID 28962591›Full record

ArticleJournal for immunotherapy of cancer2017

Erratum to: Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma.

Ashish M Kamat, Joaquim Bellmunt, Matthew D Galsky, Badrinath R Konety, Donald L Lamm, David Langham, Cheryl T Lee, Matthew I Milowsky, Michael A O'Donnell, Peter H O'Donnell and 7 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal for immunotherapy of cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Ashish M KamatUniversity of Texas MD Anderson Cancer Center, 1515 Pressler Unit 1373, Houston, TX, 77030, USA. akamat@mdanderson.org.
Joaquim BellmuntDana-Farber Cancer Institute, Brookline, MA, 02446, USA.
Matthew D GalskyTisch Cancer Institute at Mount Sinai Medical Center, New York, NY, 10029, USA.
Badrinath R KonetyUniversity of Minnesota, Minneapolis, MN, 55455, USA.
Donald L LammBCG Oncology, Phoenix, AZ, 85032, USA.
David LanghamBladder Cancer Advocacy Network, North Carolina Triangle Chapter, Chapel Hill, NC, 27517, USA.
Cheryl T LeeThe Ohio State University Wexner Medical Center, Columbus, OH, 43210, USA.
Matthew I MilowskyUniversity of North Carolina, Chapel Hill, NC, 27599, USA.
Michael A O'DonnellUniversity of Iowa, Iowa City, IA, 52242, USA.
Peter H O'DonnellUniversity of Chicago, Chicago, IL, 60637, USA.
Daniel P PetrylakYale Cancer Center, New Haven, CT, 06520, USA.
Padmanee SharmaUniversity of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Eila C SkinnerStanford University, Stanford, CA, 94305, USA.
Guru SonpavdeUniversity of Alabama, Birmingham, AL, 35294, USA.
John A TaylorUniversity of Kansas Cancer Center, Kansas City, KS, 66160, USA.
Prasanth AbrahamUniversity of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Jonathan E RosenbergMemorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID28962591
PMCPMC5622592

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.